Monogram Orthopaedics Secures Funding and Pursues FDA Approval

Monogram Orthopaedics Inc ( (MGRM) ) has issued an announcement.

Monogram Technologies Inc. successfully closed its Series D Preferred Stock offering on October 1, 2024, raising around $13 million with an oversubscribed public offering thanks to the participation of 3,023 investors. This capital boost is aimed at fueling the company’s near-term commercialization milestones, clinical trials, and further tech development. Simultaneously, Monogram is working towards obtaining FDA clearance for its orthopedic surgery innovations, signaling investor confidence in the company’s vision and future prospects.

Find detailed analytics on MGRM stock on TipRanks’ Stock Analysis page.